Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial

Douglas Brand, Alison Tree, Peter Ostler, +49

The Lancet Oncology

Familiar Medical Quotations.

D. Dodds

Annals of Internal Medicine

Humanity And MedicinePhilosophy Of MedicineMedical EthicsLiterary CriticismPatient Safety +8

Central neurocytoma: A clinical study of response to chemotherapy

D. Dodds, J. Nonis, MP Mehta, +1

Journal of Neuro-Oncology

Liposomal distribution in malignant glioma

Aya Khalifa, D. Dodds, R. Rampling, +2

Nuclear Medicine Communications

EngineeringPathologyWhole-body ImagesHigh-grade GliomasGlioma +20

Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

Chris Parker, Noel W. Clarke, Adrian Cook, +2524

The Lancet

Remobilization of patients who fail to achieve minimal progenitor thresholds at the first attempt is clinically worthwhile

Michael Watts, Stuart J. Ings, Michael Flynn, +3

British Journal of Haematology

Progenitor CellsCell TherapyImmunologySurgeryStem Cell Infusion +20

Guidelines for the diagnosis, prevention and management of chemical- and radiation-induced cystitis

Anne Thompson, Andrew Adamson, Amit Bahl, +8

Journal of Clinical Urology

Cancer Treatment-induced HcUrologyExpert OpinionMedicineGastroenterology +11

Real‐world uptake, safety profile and outcomes of docetaxel in newly diagnosed metastatic prostate cancer

R. Rulach, Stephen McKay, S. Neilson, +16

British Journal of Urology

Combination v. sequential therapy with melphalan, 5-fluorouracil and methotrexate for advanced ovarian cancer.

Andrea Miller, D. A. Boyes, D. Dodds, +5

PubMed

OncologyAdvanced Ovarian CancerGood PrognosisMedicineSequential Chemotherapy +11

Remobilization of patients who fail to achieve minimal progenitor thresholds at the first attempt is clinically worthwhile

Michael Watts, Stuart J. Ings, Michael Flynn, +3

British Journal of Haematology

Progenitor CellsCell TherapyImmunologySurgeryStem Cell Infusion +20